"10.1371_journal.pone.0018208","plos one","2011-04-05T00:00:00Z","Yangsoo Jang; Dawn Waterworth; Jong-Eun Lee; Kijoung Song; Sujin Kim; Hyo-Soo Kim; Kyung Woo Park; Hyun-Jai Cho; Il-Young Oh; Jeong Euy Park; Bok-Soo Lee; Hyo Jeong Ku; Dong-Jik Shin; Jong Ho Lee; Sun Ha Jee; Bok-Ghee Han; Hye-Yoon Jang; Eun-Young Cho; Patrick Vallance; John Whittaker; Lon Cardon; Vincent Mooser","Division of Cardiology, Cardiovascular Genome Center, Yonsei University College of Medicine, Yonsei, South Korea; Genetics Division, Medicine Discovery and Development, Research and Development, GlaxoSmithKline, Philadelphia, Pennsylvania, United States of America and Greenford, United Kingdom; DNA Link Inc. Seoul, South Korea; Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea; Division of Cardiovascular Disease, Samsung Medical Center, Sung Kyun Kwan University, Seoul, South Korea; Department of Food and Nutrition, College of Human Ecology, Yonsei University, Seoul, South Korea; Department of Epidemiology and Health Promotion, Institute for Health Promotion, Graduate School of Public Health, Yonsei University, Seoul, South Korea; Center for Genome Science, National Institute of Health, Seoul, South Korea; Medicine Discovery and Development, Research and Development, GlaxoSmithKline Philadelphia, Pennsylvania, United States of America and Greenford, United Kingdom","Conceived and designed the experiments: YJ DW J-EL KS JW LC VM PV. Performed the experiments: SK J-EL H-YJ E-YC. Analyzed the data: YJ KS DW JW H-YJ E-YC LC VM. Contributed reagents/materials/analysis tools: YJ H-SK KWP H-JC I-YO JEP B-SL HJK D-JS JHL SHJ B-GH. Wrote the paper: YJ DW J-EL KS JW LC VM PV.","Dawn Waterworth, Kijoung Song, Patrick Vallance, John Whittaker, Lon Cardon and Vincent Mooser are full-time employees of GlaxoSmithKline. GlaxoSmithKline is a pharmaceutical company which has in late-stage development an inhibitor of the Lp-PLA2 enzyme (ClinicalTrials.gov identifiers NCT00799903 and NCT01000727) Jong-Eun Lee, Sujin Kim, Hye-Yoon Jang and Eun-Young Cho are employees of DNA Link Inc, a genomic company installed in Seoul, South Korea. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","04","Yangsoo Jang","YJ",22,TRUE,8,4,8,8,TRUE,TRUE,FALSE,0,NA,FALSE
